Literature DB >> 9092512

Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA.

R Sharf1, D Meraro, A Azriel, A M Thornton, K Ozato, E F Petricoin, A C Larner, F Schaper, H Hauser, B Z Levi.   

Abstract

Two families of transcription factors mediate interferon (IFN) signaling. The first family, signal transducers and activators of transcription (STATs), is activated within minutes of IFN treatment. Specific phosphorylation events lead to their translocation to the nucleus, formation of transcriptional complexes, and the induction of the second family of transcription factors termed interferon regulatory factors (IRFs). Interferon consensus sequence binding protein (ICSBP) is a member of IRF family that is expressed only in cells of the immune system and acts as a transcriptional repressor. ICSBP binds DNA through the association with other transcription factors such as IRF-1 or IRF-2. In this communication, the domain that is involved in protein-protein interactions was mapped to the carboxyl terminus of ICSBP. This domain is also important for mediating ICSBP-repressing activity. In vitro studies demonstrated that direct binding of ICSBP to DNA is prevented by tyrosine (Tyr) phosphorylation. Yet, Tyr-phosphorylated ICSBP can bind target DNA only through the association with IRF-2 and IRF-1. This type of phosphorylation is essential for the formation of heterocomplexes. Tyr-phosphorylated ICSBP and IRF-2 are detected in expressing cells constitutively, and Tyr-phosphorylated IRF-1 is induced by IFN-gamma. These results strongly suggest that like the STATs, the IRFs are also modulated by Tyr phosphorylation that affects their biological activities.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9092512     DOI: 10.1074/jbc.272.15.9785

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.

Authors:  A L Brass; A Q Zhu; H Singh
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

2.  DNA binding and transcription activation by chicken interferon regulatory factor-3 (chIRF-3).

Authors:  C E Grant; D L May; R G Deeley
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

3.  A novel interferon regulatory factor (IRF), IRF-10, has a unique role in immune defense and is induced by the v-Rel oncoprotein.

Authors:  Jirí Nehyba; Radmila Hrdlicková; Joan Burnside; Henry R Bose
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

4.  Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors.

Authors:  B Lubyova; P M Pitha
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Anaplasma phagocytophilum modulates gp91phox gene expression through altered interferon regulatory factor 1 and PU.1 levels and binding of CCAAT displacement protein.

Authors:  Venetta Thomas; Swapna Samanta; Caiyun Wu; Nancy Berliner; Erol Fikrig
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

6.  The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8.

Authors:  Prafullakumar Tailor; Tomohiko Tamura; Hee Jeong Kong; Toru Kubota; Mayumi Kubota; Paola Borghi; Lucia Gabriele; Keiko Ozato
Journal:  Immunity       Date:  2007-08-16       Impact factor: 31.745

7.  Interferon consensus sequence binding protein (ICSBP) decreases beta-catenin activity in myeloid cells by repressing GAS2 transcription.

Authors:  Weiqi Huang; Wei Zhou; Gurveen Saberwal; Iwona Konieczna; Elizabeth Horvath; Efstratios Katsoulidis; Leonidas C Platanias; Elizabeth A Eklund
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

8.  Dynamic protein associations define two phases of IL-1beta transcriptional activation.

Authors:  Yue Zhang; Simona Saccani; Hyunjin Shin; Barbara S Nikolajczyk
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

9.  Cholera toxin inhibits IL-12 production and CD8alpha+ dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function.

Authors:  Andrea la Sala; Jianping He; Leopoldo Laricchia-Robbio; Stefania Gorini; Akiko Iwasaki; Michael Braun; George S Yap; Alan Sher; Keiko Ozato; Brian Kelsall
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

10.  Azithromycin suppresses interleukin-12p40 expression in lipopolysaccharide and interferon-gamma stimulated macrophages.

Authors:  Keiko Yamauchi; Yoko Shibata; Tomomi Kimura; Shuichi Abe; Sumito Inoue; Daisuke Osaka; Michiko Sato; Akira Igarashi; Isao Kubota
Journal:  Int J Biol Sci       Date:  2009-10-23       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.